2-[3-({cyclopropyl[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)-1H-indol-1-yl]-N-(propan-2-yl)acetamide

Compound number:
MolPort-008-360-044
IUPAC:
2-[3-({cyclopropyl[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)-1H-indol-1-yl]-N-(propan-2-yl)acetamide
IUPAC traditional:
2-[3-({cyclopropyl[(1-methylimidazol-2-yl)methyl]amino}methyl)indol-1-yl]-N-isopropylacetamide
SMILES:
CC(C)NC(=O)Cn1cc(CN(Cc2nccn2C)C2CC2)c2ccccc12
InChI key:
CMBNIXMGFGEOMH-UHFFFAOYSA-N
Molecular formula:
C22H29N5O
Molecular weight: 379.508
Sample Reformatting

Marketplace Offers

S&H to USA: 45.00 USD
S&H to World: 85.00 USD

Supplier Catalogue Data


Catalog: Screening compound Ships out: 7 business days Purity: 90%
Last updated: 3 months ago In warehouse: 1.00 mg
Pack size Ships out Price Qty
5 micromol November 4, 2019 48.00 USD
ADD TO CART
1 mg November 4, 2019 40.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-008-360-044

Names, Synonyms and 3rd Party Identifiers
Name: ZINC000055575882
2-[3-({cyclopropyl[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)-1H-indol-1-yl]-N-isopropylacetamide

InChI
InChI: 1S/C22H29N5O/c1-16(2)24-22(28)15-27-13-17(19-6-4-5-7-20(19)27)12-26(18-8-9-18)14-21-23-10-11-25(21)3/h4-7,10-11,13,16,18H,8-9,12,14-15H2,1-3H3,(H,24,28)
InChI key: CMBNIXMGFGEOMH-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C22H29N5O
Molecular weight: 379.508

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


Compound sale
2019 MolPort, v3.24, release date 22-10-2019 18:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.